GlucoRx showcases non-invasive glucose monitor at Medica 2022
14 Nov 2022
UK-based GlucoRx have joined the ABHI UK Pavilion at Media 2022 to showcase a multi-sensor non-invasive continuous glucose monitor (CGM), heralding a new era of needle-free monitoring for people with diabetes.
The GlucoRx BioXensor uses patented radio frequency technology alongside a multiple sensor approach to measure blood glucose levels every minute reliably, accurately, and non-invasively.
According to the World Health Organization, approximately 422 million people around the globe have diabetes. Currently, many patients have to prick their finger to extract and test their blood several times a day using glucometers, or apply semi-invasive devices such as continuous blood glucose monitors (CGMs).
The GlucoRx BioXensor now provides an alternative to blood glucose monitoring for the first time by measuring levels from 3 mmol/l to 30 mmol/l. When used as an early intervention to change lifestyle, the GlucoRx BioXensor can assist in preventing the onset of diabetes, or its remission, and improve quality of life with its smart alarms and remote monitoring technology.
Chris Chapman, GlucoRx chief operating officer, said: “We are excited about this life-changing end-to-end diabetes monitoring platform of ours which can be discreetly stuck on the skin to monitor blood glucose, giving readings every minute on smart mobile applications.
“GlucoRx BioXensor has standout accuracy owing to its multi sensor approach capturing blood glucose as well as Sp02, ECG, respiration rate, heart rate, temperature, activity, sleep, and early fall detection. The wearable device has a longer shelf-life because it is not chemical in its action.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.